VD
Vamil Divan Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
48
Avg Return
Past Year
Past Year
19%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $35 |
37%
upside
| 1 | +0.02% |
0
%
| 24 Nov ‘25 9 days ago |
|
|
|
Buy
Maintained
| $17 |
42%
upside
| 1 | +41% |
0
%
| 18 Nov ‘25 15 days ago |
|
|
|
Buy
Maintained
| $8 |
403%
upside
| 1 | -1.9% |
0
%
| 18 Nov ‘25 15 days ago |
|
|
|
Buy
Maintained
| $115 |
39%
upside
| 2 | +8.4% |
0
%
| 10 Nov ‘25 23 days ago |
|
|
|
Buy
Maintained
| $3 |
355%
upside
| 1 | -12% |
0
%
| 28 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $242 |
5%
upside
| 1 | +5.2% |
0
%
| 20 Oct ‘25 1 month ago |
|
|
|
Buy
Upgraded
| $206 |
0%
upside
| 1 | +18% |
0
%
| 23 Sep ‘25 2 months ago |
|
|
|
Buy
Maintained
| $11 |
75%
upside
| 1 | +81% |
0
%
| 9 Sep ‘25 2 months ago |
|
|
|
Buy
Maintained
| $13 |
50%
upside
| 1 | +16% |
0
%
| 8 Sep ‘25 2 months ago |
|
|
|
Buy
Maintained
| $172 |
17%
downside
| 1 | +41% |
0
%
| 8 Sep ‘25 2 months ago |
|
|
|
Buy
Maintained
| $39 |
11%
upside
| 1 | +81% |
0
%
| 8 Sep ‘25 2 months ago |
|